New strategy to attack aggressive brain cancer shows promise
Time:2024-05-21 13:06:05 Source:styleViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Medics remove 150 MAGGOTS from a woman's mouth after dental procedure left her with rotting tissue
You may also like
- Kate Hudson hits the stage to debut songs from her new album Glorious at star
- China's fiscal budget well implemented in 2023
- Feature: Australian winemaker excited about re
- Xizang reports robust foreign trade growth in Jan
- Liverpool confirms Arne Slot as Jurgen Klopp's replacement
- China's car rental market posts robust performance during Spring Festival holiday
- Hengqin starts new customs operation in S China
- China ready to unleash growth potential
- Iran helicopter crash that killed President Raisi could reverberate across the Middle East